CVS Initial & Final

8/21/23

CVS Caremark Mail Order Pharmacy
1780 Wall St
Mt Prospect, IL 60056
Attn: Joshua M Andersen, Pharmacist in Charge (PIC)
Illinois License Num 051289323, Registered Pharmacist

Initial & Final

C:\Temp\soopers_pharm\law
law_01.txt
3.00.50 Initial Interpretation and Final Evaluation.

a. Initial interpretation means the review of an order accompanied by order entry. The pharmacist(s) conducting the initial interpretation shall be held accountable for the accuracy of the electronic order entry/manual transcription and for drug regimen review.

b. Final evaluation means the review of the final prescription to ensure that the ordered medication is properly prepared and placed in a suitable container with appropriate labeling. The pharmacist(s) conducting the final evaluation shall be held accountable for assuring that the identity of the drug that appears on the prescription label corresponds with identity of drug contained therein. When refills are dispensed, the pharmacist conducting the final evaluation shall be held accountable for the appropriate dispensing of refills including all drug utilization reviews as they pertain to refill dispensing.

c. Drug regimen review includes but is not limited to the evaluation of order(s) and patient records(s) for:
1) Known allergies;
2) Rational therapy and contraindications;
3) Reasonable dose, duration of use, and route of administration considering age, gender, and other patient factors;
4) Reasonable directions for use;
5) Potential or actual adverse drug reactions;
6) Drug-drug interactions;
7) Drug-food interactions;
8) Drug-disease contraindications;
9) Therapeutic duplication;
10) Proper utilization (including over- or under-utilization) and optimum therapeutic outcomes; and
11) Abuse/misuse.

d. A pharmacist shall conduct an initial interpretation of each new order and a pharmacist shall conduct the final evaluation of each order dispensed. When refills are dispensed, the pharmacist making the final evaluation shall be held accountable for the appropriate dispensing of refills. The pharmacist manager shall be held accountable for the maintenance of all appropriate records.

e. The pharmacist making the initial interpretation and final evaluation on prescription or LTCF chart orders shall be identified by either license number, initials, name, or secure electronic identifier on a uniformly maintained, readily retrievable document. The uniformly maintained, readily retrievable document shall bear the license number, initials, name, or secure electronic identifier of any additional pharmacists involved in the dispensing of the order. The pharmacist conducting the initial interpretation and final evaluation may be the same person.

f. In the case where the computer software utilized is not password protected, the initial interpretation and final evaluation shall be maintained in a handwritten format bearing the license number, initials, or name of the responsible pharmacist. In addition, the identification of any other pharmacists involved in the dispensing shall be maintained in the same handwritten format.

3.00.51
Records of Initial Interpretation and Final Evaluation.
a. Records detailing both the initial interpretation and final evaluation shall be retained at the prescription drug outlet for each prescription dispensed and for at least two years from the date of any transaction pertaining to the order. These records shall include at least the following:
1) The license number, initials, name, or secure electronic identifier of the pharmacist conducting the initial interpretation for each new order;
2) The license number, initials, name, or secure electronic identifier of the pharmacist conducting the final evaluation for each new and refill prescription; and
3) The specific date on which each initial interpretation and final evaluation occurred. In the event the initial interpretation and final evaluation for a new order are conducted on separate dates, both dates shall be recorded to state specifically when both occurred.

b. Each outlet shall maintain, in written format, a notice detailing how initial interpretations and final evaluations are documented in the outlet. Such notice shall include and comply with the following:
1) The manner in which initial interpretations are recorded and maintained in the outlet for all new orders.
2) The manner in which final evaluations are recorded in the outlet for all new and refill prescriptions.
3) A statement that all pharmacy personnel involved in the dispensing of prescriptions have the ability to print, upon request, a record detailing the initial interpretation for each new prescription dispensed and final evaluation for each new and refill prescription dispensed.
4) Such written notice shall be signed and dated by the pharmacist manager. In the event the pharmacist manager changes, the incoming pharmacist manager shall review, sign and date the notice within seventy-two hours of assuming the duties of pharmacist manager. In the event there is a lapse between the time one pharmacist manager ceases the duty and another assumes the duty, the previous method of recording initial interpretations and final evaluations shall remain in effect.

5) If there are any changes to the outlet’s method of documenting initial interpretations and final evaluations, a new written notice detailing the requirements of sections 1, 2, 3, and 4 above shall be executed. This notice shall detail the effective date of change.
6) The outlet shall post these notices on a wall directly next to the outlet’s most current Board registration.
7) These notices shall be retained at the outlet for a period of three years from the date last utilized.
8) In the event such notices are not posted, the pharmacist manager shall be held accountable for the failure to post the required notice and any dispensing errors. In the event such notices are not posted during the period of time between one pharmacist manager leaving the position and another assuming the position, the outlet shall be held accountable for the failure to post the required notice and any dispensing errors.

CVS Caremark
name on license =
CVS CAREMARK ADVANCED TECHNOLOGY PHARMACY LLC
dba on license =
dba CVS/Caremark
or
CarelonRx Mail #48067
Illinois License number: 054017884
Illinois Controlled Substance License number: 32*****67
Colorado License Number OSP.0006081
1780 Wall St
Mt Prospect, IL 60056
Attn: Joshua Marshall Andersen (JMA), PIC,
Illinois License Num 051289323, Registered Pharmacist
Phone: (800) 841-5550 = CVS main pharmacy number

NPI Info: NPI Number 1629341177
phone (847) 634-7959
NPI phone number is a non working number
Caremark, LLC
Maria T Markos = President, 401 770 3303

I called Maria on 8/4/23 at 9:28am
the call lasted 1:13
after 6 rings I was able to leave a message. The recorded voice said Maria Marcos was not available. I did leave a message. I asked her to call me back to confirm this was a functional phone number, and that she was the owner of the pharmacy.

8/4/23 I got a return call, at 11:40 am, caller ID 909-226-0373
transcript:
Hello this message is for Phil Rice. I am returning a call to confirm that Maria Markos is in fact president of CVS Illinois Specialty Pharmacy. Any additional questions please do not hesitate to call back. I'll give you an alternate number as well 909-799-4168. Thank you very much. Bye bye.

Rx 157322874 Metformin 500 MG
Date Filled 01/21/23
QTY = 200, MFG = AUROBINDO
PIC JMA
800 282 5366

Phone call 7/25/23
I spoke with:
Anita DeMers, Pharmacist
Arizona License SO13387

ask for
Label reprint

NDMA testing at Valisure

Name and License number of the pharmacist who dispensed this prescription

Valisure letter to the FDA dated 3/2/20. Letter refers to the presence of N-Nitrosodimethylamine (NDMA) in specific batches of Metformin.

The World Health Organization (WHO) and the International Agency for Research on Cancer (IARC) have classified NDMA as a "probable carcinogen".

It is a 16 page letter. The above is what I got from page 1. When I skip ahead to the top of page 15:

Valisure's data clearly shows that NDMA contamination above FDA acceptable limits is a pervasive and scattered problem throughout the current American supply chain.

Complaint Items:
Label Print is too small, pharmacy address.

Department of Financial and Professional Regulation
Division of Professional Regulation
Complaint Intake Unit
555 West Monroe Street, 5th Floor
Chicago, IL 60661
Phone: (312) 814-6910

8/22/13 https://businessfacilities.com/cvs-caremark-opens-mail-service-pharmacy-and-customer-center-in-mount-prospect-il/ CVS Caremark Opens Mail Service Pharmacy And Customer Center In Mount Prospect, IL

Posted by Heidi Schwartz

CVS Caremark has opened its new state-of-the-art Mail Service Pharmacy and Customer Center in Mt. Prospect, IL. The 150,000 square foot facility, representing an investment of approximately $67 million, supports pharmacy inventory and fulfillment needs across the CVS Caremark Pharmacy Benefit Management (PBM) book of business, which serves approximately 60 million members throughout the United States. With the capability to fill 50 million prescriptions annually, this new facility is an example of CVS Caremark’s continued investment and commitment to the State of Illinois.

During the recent ribbon cutting ceremony, CVS Caremark officials took the opportunity to recognize and thank supporters from the state and region who helped make the development of the Mt. Prospect mail service pharmacy possible. In fact, 59 Illinois-based businesses were used during the construction of the facility.

The new facility will employ more than 400 people by the end of 2013 including pharmacists, pharmacy technicians, automation technicians and process improvement engineers. Proprietary technology at the facility enables 90 percent of prescriptions to be dispensed and 80 percent of prescriptions to be packaged for mailing using full automation.

“We are pleased that CVS Caremark chose to build this new state-of-the-art facility in Mt. Prospect, IL,” said Gov. Pat Quinn. “I appreciate the role that CVS Caremark plays both as a national health care innovator and as an employer in our community.”

I spoke with Gilda Morgan
Aetna
San Antonio, TX
Supervision, Clinical Care
According to my notes:
She gave me the name of the PIC at: CVS Caremark Pharmacy
1780 Wall St
Mt. Prospect, IL 60058
Joshua M Andersen (JMA)

Received 7/18/23
date filled = 7/14/23

180 Tamsulosin Hydrochloride Cap 0.4 MG
90 Furosemide Tab 20 MG
90 Levothyroxine Sodium Tab 50 MCG filled 7/15
180 Topiramate Tab 100 MG
180 Metoprolol Tartrate Tab 25 MG
90 Atorvastatin Calcium Tab 40MG

Philip G Rice
11268 E Linvale Dr
Aurora, CO 80014

(970) 235-0470
phil.rice@mkgappraisal.com

-- End of Letter --

Navigate:

home / site map / disclaimer

Philip G Rice

resume, FoaF, OPML, RSS Feed , Business Card - scanned image, vCard file. - Casey Kim (562) 382-6465